Reuters: Health
An experimental cancer drug developed by AstraZeneca and Daiichi Sankyo kept metastatic breast cancer at bay for months in women who had exhausted other treatment options, its first clinical study showed.
AstraZeneca-Daiichi drug halts cancer for months in first readout
AstraZeneca-Daiichi drug halts cancer for months in first readout
Reuters: Health
An experimental cancer drug developed by AstraZeneca and Daiichi Sankyo kept metastatic breast cancer at bay for months in women who had exhausted other treatment options, its first clinical study showed.
Reuters: Health
An experimental cancer drug developed by AstraZeneca and Daiichi Sankyo kept metastatic breast cancer at bay for months in women who had exhausted other treatment options, its first clinical study showed.
Subscribe to:
Post Comments (Atom)
Popular Posts
|
No comments:
Post a Comment